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Introduction. We reviewed our experience with limb occlusion after EVAR in order (1) to assess the clinical pattern and
treatment options (2) to assess outcomes and (3) to identify predictive factors of occurrence.
Materials and method. Between 1995 and 2005, 460 AAA patients were electively treated with a variety of commercially
available stent grafts. There were 369 bifurcated and 91 aortouniiliac grafts (829 limbs). Follow-up included physical
examination, plain X-ray, Duplex ultrasonography, and spiral computed tomographic scans at 1, 6, 12 months and annually
thereafter. All pertinent data were collected prospectively and analysed retrospectively. The follow-up period ranged from
Day 0 to 104 months, with a median follow-up of 23.4 months.
Results. 36 limbs in 33 patients (7.2%) occluded between Day 0 and 71 months (average: 9.5 months) after EVAR. Pre-
sentation was acute ischemia in 11 cases, rest pain in 9, claudication in ten. Four occlusions remained asymptomatic and
two occurred intraoperatively. Treatment was femoro-femoral cross-over graft in 19 cases, axillo-femoral bypass in three,
thrombectomy and stent in three, thrombolysis and stent in nine, and conservative in two. One patient (3%) died of
multiple organ failure after thrombolysis. There was no amputation. Reocclusions occurred in two patients (6.1%).
Multivariate logistic regression showed that kinking (odds ratio [OR] 11.9; confidence interval [CI] 3.39e42.1;
p¼ 0.0001), first graft generation (OR 2.87; CI 1.25e6.62; p¼ 0.017) and younger age (OR 1.05; CI 1.00e1.09;
p¼ 0.034) were independently related to the occurrence of graft limb occlusion.
Conclusion. Acute graft limb occlusion is not rare after EVAR. The frequency of limb occlusion has declined with current
stent grafts generation. Although surgery and endovascular treatments are efficient and safe, development of a graft limb
kink should lead to aggressive pre-emptive treatment to prevent occlusion.
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anatomic bypass.Introduction
Lower extremity ischemia is a known adverse event
following endovascular abdominal aortic aneurysm
repair (EVAR). Limb occlusion, embolism or access
related problems1 are the main causes. So far, few
studies2e4 have specifically investigated this compli-
cation and studied the predictive factors.
We report herein our ten year experience with graft
limb occlusion which occurred in patients who under-
went EVAR in our institution.
*Corresponding author. J.P. Becquemin, Departments of Vascular
Surgery and Vascular Imaging, Henri Mondor Hospital, AP/HP,
University Paris Val de Marne, Creteil 94000, Paris, France.
E-mail address: jpbecquemin@hotmail.com1078–5884/000059+ 07 $32.00/0  2007 Elsevier Ltd. All rights resThe main objectives of this study were (1) to
describe the clinical pattern and treatment options
(2) to assess outcomes and (3) to identify predictive
factors that could contribute to the occurrence of graft
limb occlusion.
Methods
Between January 1995 and November 2005, 460
patients underwent endovascular treatment of an
infrarenal abdominal aortic aneurysm in the depart-
ment of vascular surgery of Henri Mondor Hospital.
Clinical and anatomical data, operative managements
and outcomes were collected prospectively and ana-
lysed retrospectively. For the purpose of this study weerved.
60 F. Cochennec et al.excluded from the analysis three patientswho required
acute conversion following failed EVAR deployment.
Commercially available devices were used during
this period. It included 310 Zenith, 60 Vanguard, 31
Gore, 21 AneurX, 14 EVT, 9 Stenford, 8 Stentor and
7 Talent. There were 369 bifurcated devices and 91
aortomonoiliac devices combined with femorofemoral
bypass grafts, yielding a population of 829 limbs at
risk for occlusion.
Endovascular grafts were deployed below the renal
arteries in 145 cases and across the renal arteries in the
remaining 315 cases. Distally limbs were deployed
either in the common iliac artery or in external iliac
artery, depending on the extent of the aneurysm.
Following graft deployment, the entire length of the
grafts was modelled with balloon dilatation. At the
end of the procedure, control angiography was per-
formed to asses proper graft function. Great care
was taken to treat any severe kinks or stenosis which
led in some instances to additional bare stent
placement.
Post-operatively patients were prescribed anti-
platelets in routine. Five per cent of them were taking
Coumadin, the indication of which was arythmia or
cardiac disorders.
At one month, six months, 12 months and annually
thereafter, patients were systematically reviewed for
physical examination, plain X-ray, duplex ultrasono-
graphy, spiral computed tomographic scans. When
clinical symptoms suggested endograft thrombosis,
CT scan or angiography and duplex scans were
obtained.
Patients with limb graft occlusion recognized by
Duplex scan, CT-scan or arteriogram constitute the
basis of the current study. They were compared to
the group of patients who did not experience occlusion
of graft limbs.
Analysis was carried out on: (a) patient’s pre-
operative data: age, gender, smoking, dyslipidemia,
cardiac past history, renal insufficiency, hyperten-
sion, clinical presentation, (b) aneurysm features:
diameter and angulation of the iliac arteries mea-
sured on intra-operative angiography, outflow,
presence of thrombus in the infra renal aortic neck
(c) stent graft used: configuration (bifurcated or
aortouniiliac), type of device, extension of the limb
of the graft to the external iliac artery, (d) grafts
surveillance events during follow-up: migration,
limb kinking.
Poor outflow was defined as a stenosis or an occlu-
sion distal to the extremity of the limb of the graft
identified on Duplex scan or CT-scan. Only common
femoral or external iliac artery lesions were consid-
ered for the analysis.Eur J Vasc Endovasc Surg Vol 34, July 2007Migration was defined as a displacement of the
graft of at least one centimetre on CT-scan examination
as compared to the first post-operative CT-scan.
Kink was defined as a sharp localized angulation
>90 of one or both limbs of the graft on plain X-ray
examination.
Statistics
Results were expressed as percentages, mean 1 stan-
dard deviation or median, depending on variable
distribution. Patients were considered as the unit
of analysis for clinical data analysis; limbs were the
unit of analysis for anatomical data analysis. For com-
parison, categorical variables were analysed using chi
square test or Fisher’s exact test when appropriate.
Continuous variables were analysed using Student’t
test or non parametric Mann Whitney test when
appropriate. Statistically significant variables ( p< .05)
identified in the univariate analysis were further
assessed by a multivariate logistic regression. The
Kaplan-Me€ıer method was used to estimate time to
occurrence graft limb occlusion. Most significant
factors were compared with means of log-rank test.
All tests were 2-tailed and considered significant for
p 0.05.
Results
The series included 460 patients, 25 women (5.4%)
and 435 men (94.6%), with a mean age of 72.3 þ/
8 years (range, 47e88 years). All grafts were success-
fully deployed. The follow-up period ranged from
day 0 to 104 months, with a mean follow-up of 28
months (median: 23.4 months). Median follow-up
was 26.2 month for patients with graft limb occlusion
and 22.3 for patients without graft limb thrombosis.
During follow-up, 25 patients (5%) were lost to
follow-up before the end of the study and 18 (4%)
had died.
Thirty-six limbs in 33/460 (7.2%) patients occluded
at some time during follow-up.
Clinical pattern and treatment options
Limb thrombosis was unilateral in 30 patients (91%)
and bilateral in three (9%). Median time to occlusion
was 1.4 months ranging from Day 0 to 71 months.
Two patients (6.1%) occluded their grafts intra opera-
tively, 9 (27.3%) within the first week, 14 (42.4%)
within the first month, 23 (69.7%) within the first six
months and 30 (90.9%) within the first 3 years (Fig. 1).
61Limb Graft Occlusion Following EVARExcluding the two patients who occluded their
graft intra operatively, presenting symptoms were as
follows: nine patients (27%) presented with acute
ischemia, eight (24%) with rest pain and ten (30%)
with claudication. In four patients (12%), the limb
occlusions were asymptomatic and were found on
systematic duplex-scan.
Treatment options are listed in Table 1. Whenever
feasible an endovascular option was chosen first.
Catheter directed intra arterial thrombolysis was cho-
sen for patients with recent occlusion (<14 days), and
no general contra-indication was present. After bra-
chial puncture, the catheter was introduced from the
arm and pushed into the thrombus. Thrombolysis
was continued until the clots were cleared, for a max-
imum of 48 h. Any underlying causes were then
treated which included stent placement. Surgery
(including mechanical thrombectomy and extra-
anatomic bypass)wasperformed in all other situations.
Outcomes
Out of the thirty-three patients who occluded, 32
(97%) survived. The remaining patient died (3%).
This patient with a poor cardiac and pulmonary
function was treated by EVAR for a >7 cm large
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Fig. 1. Time interval to graft limb occlusion after EVAR. Of
note, three patients occluded after three years.
Table 1. Treatment options and outcome of graft limb occlusions
Treatment Patients with occluded
limb(s) (n¼ 33) n (%)
Endovascular 9 (27.2)
Thrombectomyþ stent 3 (9.1)
Thrombolysisþ stent 6 (18.2)*
Surgery 22 (66.7)
Femorofemoral bypass 19 (57.6)
Axillofemoral bypass 3 (9.1)
Conservative 2 (6.1)
* Three bilateral thrombolysis and stenting for bilateral graft limb
occlusion.asymptomatic aneurysm. After a few months, he
presented with a bilateral acute ischemia of the lower
extremities and an occluded graft. Intra-arterial
thrombolysis restored the flow but the patient died
of multiple organ failure four days afterwards.
After treatment, all alive patients cleared their
symptoms without any lasting sequelae. However,
three of these patients (9.4%) required a second re-
intervention. Two patients (6.2%) experienced graft
limb reocclusion. These two patients had been
initially treated with thrombolysisþ stenting. Reinter-
vention consisted in a successfully iterative thrombo-
lysisþ stenting of the occluded limb in one and
explantation of the endograft with aortobiilac bypass
in the second case. The third patient developed a sep-
sis of the groin. This patient had been treated with
a femoro-femoral graft and needed a new femoro-
femoral graft using a cryopreserved allograft. He
was still alive at the completion of the study. No
patient was amputated.
The two patients treated conservatively remained
asymptomatic with a follow-up period of three and
seven years respectively.
In summary 32/33 (97%) patients survived symp-
tom free and 29/33 (87.9%) experienced an uneventful
outcome after reoperation.
Analysis of predictive factors of thrombosis
Patient’s related factors
Patients who developed graft limb thrombosis were
significantly younger as compared with patients with-
out graft limb occlusion (mean age: 68.5 versus 72.6;
p¼ .007). For remaining factors, statistical analysis
failed to show a significant association between limb
thrombosis and gender, current smoking, hyperten-
sion, dyslipidemia, renal insufficiency, cardiac failure,
coronary artery disease, arythmia (Table 2).
Table 2. Variables investigated for association with graft limb
thrombosis
Clinical variables Patients with
graft limb
occlusion (n¼ 33)
Patients with
patent graft
(n¼ 427)
p
Age (mean þ/ SD) 68.5 þ/ 8 72.6 þ/ 9 .007
Male 31 (94%) 404 (95%) .70
Current smoking 17 (51%) 178 (42%) .29
Hypertension 22 (67%) 226 (53%) .14
Dyslipidemia 11 (33%) 117 (28%) .48
Coronary disease 13 (39%) 185 (46%)* .45
Cardiac failure 10 (30%) 98 (24%)** .28
Arythmia 4 (12%) 64 (15%) .80
Renal insufficiency 2 (6%) 48 (1%) .56
* Data missing for 26 patients.
** Data missing for 13 patients.Eur J Vasc Endovasc Surg Vol 34, July 2007
62 F. Cochennec et al.Aneurysm’s related factors
Statistical analysis failed to show any significant asso-
ciation with clinical presentation of the aneurysm
(symptomatic or asymptomatic), existence of throm-
bus in the infra renal neck, maximal transverse dia-
meter of the aneurysm, diameter of the infra-renal
neck and iliac anatomy pattern (Tables 3 and 4).
Devices and graft configuration
Limb occlusions occurred with any type of stent-grafts
(Vanguard, EVT, Stentor, Stenford, Gore, Zenith, and
Talent) except for the AneurX device (Table 5). The
rate of limb thrombosis was higher with the first gen-
eration devices. Seventeen patients out of 91 (18.7%)
with a first generation device (EVT, Vanguard, Stentor,
Stenford) had limb thrombosis. Conversely, only 16 of
369 patients (4.3%) treated with currently available
stent-grafts (Talent, AneurX, Gore, Zenith) occluded
their grafts (P< .001). The highest rates of limb occlu-
sion were observed with the EVT graft (4/14, 28.6%)
and Stenford device (3/9, 33.3%).
Graft migration, kink and outflow
Graft migration as defined above was recognized in 9
cases and was not identified as a predictive factor of
occlusion (Table 3).
Graft limb kinking occurred in 14 limbs of 13 pa-
tients. Limbs with kinking were more likely to experi-
ence limb thrombosis than limbs without kinking.
Thrombosis occurred in 8 of 14 limbs (57.1%) with
limb kinking and in 28 of 815 limbs (3.4%) without
kinking (P<.001). Fig. 2 shows the comparison of sur-
vival curves free of thrombosis in patients with or
without a kink of the limb of the graft. All graft
limb kinks occurred in bifurcated devices. None of
the aortomonoiliac devices developed kinking.
Poor outflow defined as iliac or common femoral
stenosis >70% occurring during the follow-up period
increased the risk of limb thrombosis. Thrombosis
occurred in 5 of 7 limbs (71.4%) with ipsi-lateral
Table 3. Aneurysm related factors investigated for association
with graft limb thrombosis
Variables Patients with
graft occlusion
(n¼ 33)
Patients with
patent graft
(n¼ 427)
p
Symptoms n (%) 0 33 (8) .15
Thrombus in the infrarenal
neck: n (%)
24 (73) 324 (76) .68
Maximal transverse diameter
(cm) mean þ/ SD
54.6 þ/ 10 56.5 þ/ 13 .33
Diameter of the infrarenal
neck (cm) mean þ/ SD
22.5 þ/ 3 22.9 þ/ 4 .40
Migration of the graft: n (%) 1 (3) 8 (2) .49
SD, standard deviation.Eur J Vasc Endovasc Surg Vol 34, July 2007underlying femoral or iliac stenosis >70% and in 31
of 822 limbs (3.8%) without ipsi-lateral underlying
occlusive disease (p< 0.001).
Additional limb stenting during follow-up
We studied the relationship of additional stenting of
the limbs of the stent- grafts during follow-up and
the occurrence of occlusion. Redo stenting was per-
formed in 23 limbs, five (16%) occluded later one. In
806 limbs where no redo stenting was performed 31
limbs thrombosed (3.8%) (p¼ 0.001).
Multivariate analysis using a logistic regression
model showed that kinking (odds ratio [OR] 11.9;
95% confidence interval [95% CI] 3.39e42.1;
p¼ 0.0001), younger age ([OR] 1.05; [95% CI] 1.00e
1.09; P¼ 0.034), first generation devices ([OR] 2.87;
CI 1.25e6.62; p¼ 0.017) were independently related
to the occurrence of graft limb occlusion. Underlying
vascular stenosis could not be tested in this model
due to the small number of events.
Discussion
Endovascular repair has been increasingly used
worldwide to treat AAA. While long-term durability
still remains uncertain, EVAR has many early
Table 4. Iliac anatomy pattern investigated for association with
graft limb thrombosis
Variables Occluded
limbs (n¼ 36)
Patent
limbs (n¼ 793)
p
Maximal iliac artery
angulation > 60: n (%)
8 (23)# 158 (23)## .91
EIA* diameter (mean þ/SD) 8.8 þ/ 2.1 9.6 þ/ 4 .32
Extension of the graft to the
EIA*: n (%)
8 (22) 156 (9) .70
SD, standard deviation.
* EIA: external iliac artery (mm).
# : Data missing for two patients.
## : Data missing for 98 patients.
Table 5. Distribution of limb occlusions according to devices
Device Total (n) Patients with
limb occlusion: n (%)
Vanguard 60 8 (13)
EVT 14 4 (29)
Stenford 9 3 (33)
Stentor 8 2 (25)
Talent 7 1 (14)
AneurX 21 0 (0)
Gore 31 2 (7)
Zenith 310 13 (4)
Bifurcated 369 28 (9)
p¼ .49Aortomonoiliac 91 5 (5)
1st generation devices 91 17 (19)
p< .0011Current devices 369 16 (4)
63Limb Graft Occlusion Following EVARadvantages which may explain its liberal used in
many institutions: decrease in postoperative morbid-
ity, less blood transfusion, shorter hospital stay and
better short-term health-related quality of life.5e8
Nevertheless, the benefits come at the price of an in-
creased number of graft-related complications and
secondary procedures during follow-up.9 Limb graft
occlusion is one of these adverse events.
The rate of lower extremity ischemia after EVAR
was 7% in the current series. In previous reports
the percentage varied between 2 and 40% depend-
ing mostly upon type of grafts and duration of
follow-up.1e3,10,11
The clinical presentation in the current series
included approximately 1/3 of patient with acute
limb ischemia, while most patients presented with
less severe symptoms or were asymptomatic. These
findings are in agreement with Maldonado series.1 In
our series, the majority of limb occlusions (70%)
occurred during the first 6 months after implantation
of the stent-graft and this is again in agreement with
previous reports including Ferman’s one.12
The etiologic factors of such occlusions are impor-
tant to consider. Our analysis has found four signifi-
cant predictive factors including young age, type of
device, the presence of a kink and underlying stenotic
disease.
We have no clear explanation on the role of age
which however has been previously identified as a
factor of poor outcome in patient with peripheral
vascular disease.
The role of the generation of stent graft was under-
lined in our series. The rate of occlusion with different
stent graft is shown in Table 5. This is in agreement
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Fig. 2. Survival curves free of thrombosis in patients with or
without a kink of the limb of the graft.with the Eurostar series findings which have shown
that currently commercially available stent-grafts
had a lower incidence of complications including
occlusion than the first generation grafts.13 Although
the majority of graft limb occlusion occurred within
the first six months after EVAR which give a strong
support of our findings, the relatively small numbers
of first generation devices along with a longer follow-
up with these devices are limitations of the study.
We failed to find a statistical significance of graft’s
configuration (aortouniiliac versus bifurcated grafts)
as regard to limb occlusion. Obviously specific indica-
tion for graft configuration makes comparison debat-
able. Aortouniiliac grafts were indicated in the
presence of a narrow aortic bifurcation or in patients
with a severely diseased iliac artery on one side. In
a retrospective study of 173 endovascular AAA repair,
Carpenter et al.14 found 7 graft limb thrombosis.
Aortomonoiliac grafts with femoro-femoral bypass
grafts had a trend toward a better patency rate (97%
at 18 months) than bifurcated endografts (90% at 18
months) but as in our series, the difference was not
statistically significant.
Kink was the predominant factor of occlusion in our
series. Graft limb kinking occurred in 14 limbs of 13
patients and was significantly associated with graft
limb occlusion. Diagnosis of kink was established on
the first month X-Ray postoperatively in 7 cases and
more than one year after initial intervention in the
other 7 cases. A part from device related problems
such as those observed with the unsupported graft,
early kinks development is mostly linked to tortuosity
in the iliac arteries or blunt angled bifurcation. This
angulation may be missed when the control angio-
gram is performed before the pull out of the stiff
wire which straightens the arteries. Since a significant
number of patients had early thrombosis due to this
phenomenon, it is our current practice to perform
routinely completion angiography without stiff wires.
Sivamurthy15 has shown that in a series of Zenith stent
graft, patient in whom a bare stent had been placed in
the limb of the graft had no occlusion compared to
7.1% in patient without stents. Aneurysm shrinkage
in Eurostar database was significantly associated
with limb distortions16 which ultimately increased
the risk of occlusion. Although late kink is mostly
linked to migration of the graft, more than aneurysm
shrinkage,17 we failed to identify migration as a factor
of thrombosis. This may be explained by our policy of
aggressive management of any migration before
endoleak or occlusion occurs.
Underlying arterial diseases which developed dur-
ing the follow-up and which were detected by post-
operative Duplex scan were found to be a predictiveEur J Vasc Endovasc Surg Vol 34, July 2007
64 F. Cochennec et al.factor of occlusion. Reduced flow in the limb of the
graft due to outflow impairment is probably explana-
tory. Similarly to kink development such lesions
should not be left untreated.
Among all others factors tested in the current
series, none of patient general characteristics such as
gender, current smoking, hypertension, dyslipidemia,
renal insufficiency, cardiac failure, coronary artery
disease, and arythmia were predictive of occlusion.
Other factors such as coagulation disorders have not
been reported with stent graft but are known factors
of occlusion after open surgery.
Iliac size, angulations and distal extent of the graft
may also play a role in the occurrence of thrombosis.
Carrocacio2 identified small limb diameter (14 mm
versus 16 mm) and distal extent of the graft to the ex-
ternal iliac artery as significant factors. This later fac-
tor was also underlined by Erzurum.3 We did not find
a correlation with limb diameter but there was a trend
toward more thrombosis in the group of patient with
limbs placed into the external iliac artery. The rate of
limb occlusion occurrence was 5.1% when the ipsilat-
eral limb was extended into the external iliac artery
and 4.2% when it was not extended into the common
iliac artery (p¼ 0.7). Similarly, the population of oc-
cluded limbs had a higher mean maximal angulation
of iliac arteries (37.6 versus 28.4, P¼ 0.07). This
difference was not statiscally significant.
Treatment options
In our series, stent-graft limb thrombosis were suc-
cessfully treated with endovascular or surgical inter-
ventions in all patients except one who died
following bilateral graft limb thrombosis.
Thrombolysis followed by stenting was used in 6
cases. Reocclusion occurred in two of those cases, ne-
cessitating iterative thrombolysis with further stent
placement. Thrombolysis has been shown to be an ef-
fective modality in restoring patency in thrombosed
vascular grafts.18 The underlying limb stenosis can
then be identified and treated with stent placement.
Although thrombolysis therapy is an attractive op-
tion, it has many drawbacks. This procedure is time-
consuming, and may be complicated by leg embolism,
haemorrhages and new endoleak due to the lysis of
the thrombus in the aneurysm sack. Mechanical
thrombolysis devices may have a role in this setting.
In 2 previous reports,19,20 9 patients with graft limb
thrombosis were successfully treated with mechanical
rheolytic thrombectomy.
In our series, combined interventions including
surgical thrombectomy and stenting of the occludedEur J Vasc Endovasc Surg Vol 34, July 2007limb were successful in three cases. Nevertheless,
this treatment has its own drawback such as stent-
graft dislodgement, component separation in modular
devices and thrombus migration in the controlateral
limb and hypogastric artery. Fortunately such adverse
events did not occurred in the current series.
As noted in previous studies,21e23 extra anatomic
bypasses are very effective with patency rates above
90%. In our series, we did not observed any reocclu-
sion among 22 extra anatomic bypasses. Detection
and correction of any stenosis in the donor limb23 is
of paramount importance to maintain long term
patency. Good imaging and intraoperative pressure
measurements at the time of femorofemoral bypass
may be helpful. Contrary to thrombolysis which re-
quires refined technical equipment and ICU availabil-
ity, femoro-femoral bypasses can be safely performed
in every vascular centre.
To summarize, the choice between thrombolysis
and extra anatomical repair is not obvious. The single
death in this series occurred after thrombolysis. Con-
versely, the single infection occurred in a patient
treated with a femoro-femoral graft. Patient’s condi-
tion, severity and length of ischemia, and institutional
factors should be taken into consideration for a sound
choice.
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